Besides genetic alterations, evasion of mitochondrial apoptosis is a hallmark of clonal cells in AML and anti-apoptotic BCL-2 family members have gained interest as crucial pro-survival factors and potential drug targets [18–20]. This evidence concerns the gene BCL2 and acute myeloid leukemia.